In our study, network pharmacological analysis, transcriptomics, and DARTS techniques showed that Esc likely exerts its effects by binding with ENO1 and modulating PI3K/AKT/Stat3/mTOR signaling pathways and target processes to intervene in the development of CRC. This evidence concerns the gene MTOR and colorectal carcinoma.